Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
Details for Australian Patent Application No. 2004246812 (hide)
International Classifications
Event Publications
5 January 2006 PCT application entered the National Phase
PCT publication WO2004/110420 Priority application(s): WO2004/110420
17 December 2009 Application Accepted
Published as AU-B-2004246812
14 January 2010 Corrigenda
Applications Accepted - Name Index Under the name Ascend Therapeutics, Inc. and Northweestern University, Application No. 2004246812, under INID (71) correct the co-applicant name to Northwestern University
15 April 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004246811-Pharmaceutical formulations comprising amoxicillin and clavulanate
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser